1. 105 HIGH RESPONSE RATE FOR AZACITIDINE-LENALIDOMIDE (VI-LEN) COMBINATION IN HIGHER-RISK MYELODYSPLASTIC SYNDROMES (MDS) - VILEN-01 PROTOCOL UPDATE. (April 2015) Authors: Mittelman, M.; Filanovsky, K.; Ofran, Y.; Raanani, P.; Braester, A.; Goldshmidt, N.; Kirgner, I.; Herishanu, Y.; Perry, C.; Oster, H.S. Journal: Leukemia research Issue: Volume 39(2015:Apr.) Supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study. (July 2018) Authors: Yeshurun, M.; Vaxman, I.; Shargian, L.; Yahav, D.; Bishara, J.; Pasvolsky, O.; Wolach, O.; Lahav, M.; Gurion, R.; Magen, H.; Vidal, L.; Herscovici, C.; Peck, A.; Moshe, M.; Sela-Navon, M.; Naparstek, E.; Raanani, P.; Rozovski, U. Journal: Clinical microbiology and infection Issue: Volume 24:Number 7(2018) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anticoagulation in Thrombocytopenic Patients with Hematological Malignancy: A Multi-center, Multinational Decision Making Analysis. Issue 164 (April 2018) Authors: Leader, A.; ten Cate, V.; ten Cate-Hoek, A.; Beckers, E.; Spectre, G.; Raanani, P.; Schouten, H.; Falanga, A.; ten Cate, H. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does Bone Marrow Cellularity (BMC) Have a Role in Predicting Prognosis and Survival in Myelodysplastic Syndromes (MDS)?. (April 2017) Authors: Greenbaum, U.; Joffe, E.; Oster, H.S.; Kirgner, I.; Levi, I.; Raanani, P.; Avivi, I.; Mittelman, M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature. Issue 4 (13th October 2016) Authors: Grisariu, S.; Vaxman, I.; Gatt, M.; Elias, S.; Avni, B.; Arad, A.; Pasvolsky, O.; Raanani, P.; Paltiel, O. Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Maintenance therapy with hypomethylating agents for patients with acute myeloid leukemia in first remission not eligible for allogeneic hematopoietic cell transplantation: A systematic review and meta-analysis. (February 2022) Authors: Sherban, A.; Raanani, P.; Gurion, R.; Wolach, O.; Gafter-Gvili, A. Journal: Leukemia research Issue: Volume 113(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1166: REPEAT BIOPSY IN RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A NATIONWIDE SURVEY AND RETROSPECTIVE STUDY. (23rd June 2022) Authors: Berger, T.; Geiger, K. R.; Yeshurun, M.; Gafter-Gvili, A.; Shochat, T.; Gurion, R.; Raanani, P.; Pasvolsky, O. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION. (23rd June 2022) Authors: Zoref-Lorenz, A.; Murakami, J.; Hofstetter, L.; Abadi, U.; Iyer, S.; Mohamed, S.; Miller, P. G.; Natour, A. E. H.; Weinstein, S.; Yacobovich, J.; Izraeli, S.; Nikiforow, S.; Ebert, B.; Gurion, R.; Cohen, I.; Pasvolsky, O.; Raanani, P.; Nagler, A.; Berliner, N.; Daver, N. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P1461: CAR-T VS. STANDARD OF CARE AS SECOND LINE TREATMENT FOR LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS. (23rd June 2022) Authors: Shargian, L.; Raanani, P.; Yeshurun, M.; Gafter-Gvili, A.; Gurion, R. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1584: CELLULAR IMMUNE RESPONSE TO THE BNT162B2 VACCINE IN LYMPHOMA PATIENTS. (23rd June 2022) Authors: Gurion, R.; Rozovski, U.; Itchaki, G.; Gafter-Gvili, A.; Leibovitch, C.; Raanani, P.; Szwarcwort, M.; Taylor-Abigadol, M.; Dann, E.; Horesh, N.; Inbar, T.; Tzoran, I.; Lavi, N.; Bar Haim, E.; Cohen, H.; Slouzky, I.; Azoulay, T.; Karmona, M.; Ringelstein-Harlev, S.; Horowitz, N. A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1465 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗